1. Serum levels of soluble dipeptidyl peptidase-4 in type 2 diabetes are associated with severity of liver fibrosis evaluated by transient elastography (FibroScan) and the FAST (FibroScan-AST) score, a novel index of non-alcoholic steatohepatitis with significant fibrosis
- Author
-
Kanako Kato, Shintaro Sakurai, Teruo Jojima, Masato Kase, Isao Usui, Yoshimasa Aso, Masaaki Sagara, Takuya Tomaru, and Toshie Iijima
- Subjects
Liver Cirrhosis ,medicine.medical_specialty ,Cirrhosis ,Dipeptidyl Peptidase 4 ,Endocrinology, Diabetes and Metabolism ,Liver fibrosis ,030209 endocrinology & metabolism ,Type 2 diabetes ,030204 cardiovascular system & hematology ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Non-alcoholic Fatty Liver Disease ,Diabetes mellitus ,Internal medicine ,Internal Medicine ,medicine ,Humans ,Dipeptidyl peptidase-4 ,business.industry ,medicine.disease ,Cross-Sectional Studies ,Diabetes Mellitus, Type 2 ,Liver ,Elasticity Imaging Techniques ,Steatosis ,Steatohepatitis ,Transient elastography ,business - Abstract
To investigate the relationship in people with type 2 diabetes between serum soluble dipeptidyl peptidase-4 (sDDP-4) and degree of liver fibrosis assessed as the liver stiffness measurement (LSM) and FAST (FibroScan-AST) score, both of which were measured by transient elastography (FibroScan).In this cross-sectional study, we examined 115 patients with type 2 diabetes. With transient elastography (FibroScan), we assessed the controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) as measures of hepatic steatosis and liver fibrosis, respectively. We calculated the FAST score, which identifies progressive non-alcoholic steatohepatitis (NASH), from CAP, LSM, and the serum aspartate aminotransferase level. Significant hepatic steatosis was defined as CAP ≥280 dB/m; and significant liver fibrosis, as LSM ≥ 8.0 kPa. LSM was divided into 3 severity levels: significant fibrosis (8.0 to9.7 kPa); advanced fibrosis, (9.7 to13.0 kPa); and liver cirrhosis (≥ 13.0 kPa).Serum sDPP-4 correlated positively with liver enzymes, CAP, LSM, and FAST score. Multivariate analysis showed that LSM remained to be an independent factor for serum sDDP-4. Serum sDPP-4 was significantly higher in patients with LSM ≥ 8.0 kPa than in those with LSM8.0 kPa and was significantly elevated in patients who are at risk for non-alcoholic steatohepatitis (NASH) with fibrosis (FAST score ≥ 035 or 0.67). Patients with both hepatic steatosis and liver fibrosis had the highest serum sDPP-4.Serum sDPP-4 was strongly associated with severity of liver fibrosis evaluated by LSM and the FAST score and was markedly elevated in diabetic patients with LSM ≥ 13.0 kPa indicating probable cirrhosis.
- Published
- 2021